At close: December 13 at 4:00:01 PM EST
After hours: December 13 at 6:17:59 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
230,290.00
-70,236.00
-108,137.00
-107,865.00
-72,484.00
Investing Cash Flow
-352,045.00
-39,258.00
91,468.00
-15,860.00
-90,965.00
Financing Cash Flow
22,349.00
170,477.00
18,838.00
129,923.00
247,626.00
End Cash Position
131,346.00
186,952.00
125,969.00
123,890.00
117,818.00
Interest Paid Supplemental Data
--
--
--
--
438.00
Capital Expenditure
-1,064.00
-609.00
-795.00
-1,101.00
-471.00
Issuance of Capital Stock
8.00
132,100.00
14,553.00
123,829.00
255,365.00
Repayment of Debt
--
--
--
--
-10,524.00
Free Cash Flow
229,226.00
-70,845.00
-108,932.00
-108,966.00
-72,955.00
12/31/2020 - 8/11/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KURA Kura Oncology, Inc.
9.63
-0.62%
IDYA IDEAYA Biosciences, Inc.
25.19
-2.29%
MLTX MoonLake Immunotherapeutics
51.34
-4.52%
STOK Stoke Therapeutics, Inc.
12.06
-2.11%
COGT Cogent Biosciences, Inc.
8.15
-2.28%
VRDN Viridian Therapeutics, Inc.
17.85
-0.78%
CRNX Crinetics Pharmaceuticals, Inc.
53.66
-3.52%
ANAB AnaptysBio, Inc.
15.59
+3.79%
NRIX Nurix Therapeutics, Inc.
20.27
-1.41%
ACLX Arcellx, Inc.
83.80
+0.46%